Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies (Q38313236)

2 September 2017

1 reference

title

Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

2 September 2017

hepatocellular carcinoma

1 reference

1 reference

1 reference

Kohei Oda

1

1 reference

2 September 2017

Hirofumi Uto

series ordinal

2

1 reference

2 September 2017

Seiichi Mawatari

series ordinal

3

1 reference

2 September 2017

Akio Ido

series ordinal

4

1 reference

2 September 2017

10 January 2015

1 reference

Clinical journal of gastroenterology

2 September 2017

1 reference

2 September 2017

8

1 reference

2 September 2017

1

1 reference

2 September 2017

1-9

1 reference

https://scigraph.springernature.com/pub.10.1007/s12328-014-0548-5

2 September 2017

0 references

cites work

Endpoints and clinical trial design for nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Long-term follow-up of patients with NAFLD and elevated liver enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Primary liver cancer: worldwide incidence and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Obesity-associated mechanisms of hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Increasing prevalence of diabetes mellitus in association with fatty liver in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Long-term follow-up of patients with nonalcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Population-based risk factors and resource utilization for HCC: US perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Prevalence, gender, ethnic variations, and prognosis of NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Metabolic syndrome and hepatocellular carcinoma risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Diabetes mellitus and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Fatty liver in men is associated with high serum levels of small, dense low-density lipoprotein cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Smoking as an independent risk factor for hepatocellular carcinoma: the Singapore Chinese Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Liver disease in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Non-alcoholic steatohepatitis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

White adipose tissue as endocrine organ and its role in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Adipocytokines and liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Fructose consumption as a risk factor for non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Dietary fructose in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Clinical and pathological progression of non-alcoholic steatohepatitis to hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Identification of a novel biomarker for oxidative stress induced by hydrogen peroxide in primary human hepatocytes using the 2-nitrobenzenesulfenyl chloride isotope labeling method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

A serum "sweet-doughnut" protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0548-5

The role of sugar-sweetened beverage consumption in adolescent obesity: a review of the literature

21 January 2018

1 reference

12 December 2020

Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitis

1 reference

12 December 2020

Difference in malignancies of chronic liver disease due to non-alcoholic fatty liver disease or hepatitis C in Japanese elderly patients

1 reference

12 December 2020

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

1 reference

12 December 2020

Platelet count for predicting fibrosis in nonalcoholic fatty liver disease

1 reference

12 December 2020

Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma

1 reference

12 December 2020

Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis

1 reference

12 December 2020

Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis

1 reference

12 December 2020

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

1 reference

12 December 2020

Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake

1 reference

12 December 2020

Alcohol drinking patterns and the risk of fatty liver in Japanese men

1 reference

12 December 2020

Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease

1 reference

12 December 2020

Fructose, weight gain, and the insulin resistance syndrome

1 reference

12 December 2020

Recent trend of clinical features in patients with hepatocellular carcinoma

1 reference

12 December 2020

Influence of age and gender in Japanese patients with non-alcoholic steatohepatitis

1 reference

12 December 2020

Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality

1 reference

12 December 2020

In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease

1 reference

12 December 2020

Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications

1 reference

12 December 2020

Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years

1 reference

12 December 2020

Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies

1 reference

12 December 2020

Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period

1 reference

12 December 2020

Is the control of dietary cholesterol intake sufficiently effective to ameliorate nonalcoholic fatty liver disease?

1 reference

12 December 2020

Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity

1 reference

12 December 2020

Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan

1 reference

12 December 2020

10.1007/S12328-014-0548-5

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

1045239236

0 references

Fatcat ID

release_sgivq6svi5dcpejny7m7d5gjpm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sgivq6svi5dcpejny7m7d5gjpm

24 November 2022

mapped directly with Wikidata item

1 reference